 Provider News OhioFebruary 1, 2024 February 2024 Provider Newsletter Featured Articles Administrative | Medicaid Managed Care | January 29, 2024 A message from Ohio Department of Medicaid
The Ohio Department of Medicaid (ODM) resumed Provider Revalidations in June 2023. It is imperative that providers who are due for revalidation take immediate action as terminations will resume on January 23, 2024. All providers are subject to either three (3) or five (5) year time-limited provider agreements. Prior to termination, letters are both mailed and emailed 120 days, 90 days, 60 days, and a final notice at 30 days. Providers who do not submit their revalidation could experience termination at the state level, which would cascade to the Managed Care Entities (MCEs) causing claim denials as a non-participating provider. Emails will come from OHPNM@maximus.com. Revalidations notices are posted in the Provider Network Management (PNM) module and can be accessed in the Correspondence folder. Providers will also see a “Begin Revalidation” option in the PNM Enrollment Action Selection 120 days prior to the Medicaid Agreement end date. Providers can locate this under the “Manage Application” then “Enrollment Actions” option within the provider file. Click the Revalidation/Reenrollment Quick Reference Guide for step-by-step instructions. Providers who need technical assistance can contact ODM’s Integrated Help Desk at 800-686-1516 and follow the prompts for Provider Enrollment or email IHD@medicaid.ohio.gov. To learn more about the PNM module and Centralized Credentialing, visit the PNM and Centralized Credentialing page on the Next Generation website. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-049757-24, OHBCBS-CD-050069-24 Please review your online provider directory information on a regular basis to ensure it is correct. Access your online provider directory information by visiting anthem.com, then at the top of the webpage, select Find Care. Submit updates and corrections to your directory information by following the instructions on the Provider Maintenance Form online. Update options include: - add/change an address location
- name change
- phone/fax number change
- provider leaving a group or a single location
- closing a practice location
The Consolidated Appropriations Act (CAA) implemented in 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. By reviewing your information regularly, you help us ensure your online provider directory information is current. We share a health vision with our care providers that means real change for consumers. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-049338-24 Anthem providers who administer vaccines to children through 18 years of age should enroll in the VFC program. Anthem will reimburse only the administration fee for any vaccine available through the VFC program. When submitting claims for vaccines and/or toxoids covered under the VFC program: - Providers should bill CPT® 90460 for the administration.
- When administering more than one vaccine, providers should bill the number of vaccines as units:
- For example, if two vaccines are administered the claim should be billed with an E/M code, two individual vaccines and/or toxoids, and two units of 90460.
- Anthem does not require the SL modifier to be appended.
If you have questions regarding Vaccines for Children, visit the following: - Ohio Department of Health’s website:
- ODM Guidance:
- Anthem VFC policy:
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-048214-23 Per the Ohio Department of Medicaid, all hospice claims billed on the UB04 form must be billed with the appropriate county code to be reimbursed correctly. Failure to include the correct county code will result in denial of the claim. The county code should be entered in the Value Code section of the UB04 form. The list of correct county codes can be found here. For additional information regarding hospice reimbursement, please refer to OAC 5160-56-06. As of November 1, 2023, Anthem’s system configuration has been updated to allow providers who bill on the UB04 form to bill type of bill 81x or 82x for HCPCS codes T2042-T2045, based on the type of hospice provider billing these services. If you have questions regarding hospice billing, please reach out to your Provider Relationship Account Management consultant at Ohiomedicaidprovider@anthem.com or refer to our provider website for additional information. Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partners. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-045540-23 There are new resources available for providers to complete the Pregnancy Risk Assessment Form electronically, or ePRAF (Electronic Pregnancy Risk Assessment Form). To access this form, log in to the NurtureOhio website where you will find information on how to use the ePRAF. Quality Enhancer Incentive Program for ePRAF The Quality Enhancer Incentive Program provides increased payments to eligible providers who submit the ePRAF via the NurtureOhio website on behalf of their pregnant patients. Technical Assistance Intervention Package for ePRAF The Technical Assistance Intervention Package is a collection of resources, tools, and reporting that is designed to assist Providers in delivering high-quality pregnancy related care to their patients. For more information on using the ePRAF, please contact us at ohiomedicaidprovider@anthem.com. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-048680-23, OHBCBS-CD-049383-24-SRS48922, OHBCBS-CD-049390-24-SRS48922, OHBCBS-CD-049393-24-SRS48922, OHBCBS-CD-049391-24-SRS48922, OHBCBS-CD-049392-24-SRS48922, OHBCBS-CD-048922-24-SRS48922, OHBCBS-CD-049387-24-SRS48922, OHBCBS-CD-049384-24-SRS48922, OHBCBS-CD-049388-24-SRS48922, OHBCBS-CD-049389-24-SRS48922, OHBCBS-CD-049385-24-SRS48922 This article was published in error and retracted on February 21, 2024. Please access your state's updated version: Colorado, Connecticut, Georgia, Indiana, Kentucy, Maine, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin You may submit all your prior authorizations in one application on Availity.com.
You may already be submitting your prior authorizations through the Availity multi-payer Authorization application — taking advantage of the time savings and speed to care through digital authorization submissions. Beginning in March, you can submit both your physical health and behavioral health prior authorizations through one Authorization application on Availity.com.
You can still access the Interactive Care Reviewer (ICR) to review cases that were submitted through that application. You will also continue to use ICR to submit an appeal or authorization for medical specialty Rx.
Using the Availity Authorization application to submit your behavioral health prior authorizations will not be much different from the process you follow today. You may enjoy more intuitive screens or learn sooner if an authorization is required — but the digital submission process is still the very best way to submit your prior authorization and the fastest way to care for our members.
Training is available
If you aren’t already familiar with Availity Authorization, training is available. Select Availity Authorization Training to enroll for an upcoming live webcast or to access an on-demand recording.
Now, give it a try!
Accessing the Availity for authorization is easy. Ask your organization’s Availity administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, log on to Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals.
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-049149-23-CPN48082 The Health Care Networks team for Anthem invites you to their next provider orientation in March. It will cover everything you need to know to work with Anthem. 
| Tuesday, March 26, 2024 | 11 a.m. CT |
To register for the date above, please select the following link: https://s-us.chkmkt.com/?e=352833&d=l&h=262D03BE81B2266&l=en If you have any questions, please contact your provider relationship account manager or email OhioMedicaidProvider@anthem.com. Together, through genuine collaboration, we can continue to build our shared health vision. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-048942-24 The Anthem provider relationship account management team will host our next Behavioral Health provider orientation on: 
| Wednesday, March 20, 2024 | 9 a.m. ET |
Please join us to learn more about working with us and supporting your patients, our members. Register at the following link: https://s-us.chkmkt.com/?e=371114&d=l&h=C1653FE3BDECE2A&l=en If you have questions, please contact your provider relationship account manager or email us at OhioMedicaidProvider@anthem.com. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-049219-24 Policy Updates | Commercial | February 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements MCG care guidelines 27th edition updateEffective June 1, 2024, Anthem will transition from CG-BEH-02 (Adaptive Behavioral Treatment) and MCG W0153 (Behavioral Health Care Applied Behavioral Analysis), to MCG B-806-T Behavioral Health Care Applied Behavioral Analysis (Original MCG Guideline), for medical necessity/clinical appropriateness reviews. If you have questions, please contact the provider service number on the back of the member's ID card. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047274-23 SummaryOn September 21, 2023, and October 4, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits. Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email. Please see the explanation/definition for each category of Clinical Criteria below: - New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
- Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive
Please share this notice with other providers in your practice and office staff. Please note: - The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised | February 19, 2024 | *CC-0248 | Elrexfio (elranatamab-bcmm) | New | February 19, 2024 | *CC-0249 | Talvey (talquetamab-tgvs) | New | February 19, 2024 | *CC-0250 | Veopoz (pozelimab-bbfg) | New | February 19, 2024 | *CC-0251 | Pompe Disease | New | February 19, 2024 | *CC-0018 | Pompe Disease | Revised | February 19, 2024 | *CC-0021 | Fabrazyme (agalsidase beta) | Revised | February 19, 2024 | *CC-0046 | Zinplava (bezlotoxumab) | Revised | February 19, 2024 | CC-0182 | Iron Agents | Revised | February 19, 2024 | *CC-0068 | Growth Hormones | Revised | February 19, 2024 | CC-0156 | Reblozyl (luspatercept) | Revised | February 19, 2024 | *CC-0233 | Rebyota (fecal microbiota, live – jslm) | Revised | February 19, 2024 | *CC-0020 | Natalizumab Agents (Tysabri, Tyruko) | Revised | February 19, 2024 | CC-0064 | Interleukin-1 Inhibitors | Revised | February 19, 2024 | CC-0026 | Testosterone Injectable | Revised | February 19, 2024 | *CC-0247 | Beyfortus (nirsevimab) | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-047335-23-CPN47070 Effective April 1, 2024, Anthem will transition to the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines for medical necessity/clinical appropriateness reviews for requested interventions: - Genetic Testing Guidelines:
- Carrier Screening in the Prenatal Setting and Preimplantation Genetic Testing
- Cell-free DNA Testing for the Management of Cancer
- Chromosomal Microarray Analysis
- Genetic Testing for Inherited Conditions
- Hereditary Cancer Testing
- Pharmacogenomic Testing
- Polygenic Risk Scores
- Prenatal Testing using cell-free DNA
- Somatic Tumor Testing
- Whole Exome Sequencing and Whole Genome Sequencing
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-047897-23 Medical Policy & Clinical Guidelines | Commercial | January 24, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Carelon Medical Benefits Management, Inc. genetic testing code updatesEffective for dates of service on and after May 1, 2024, the following codes will require prior authorization through Carelon Medical Benefits Management, Inc. CPT® code | Description | 0239U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations | 0306U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations | 0307U | Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient specific panel for | 0356U | Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement | 0368U | Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4, ZNF132 and TWIST1), multiplex quantitative polymerase chain reaction (qPCR), circulating cell-free DNA (cfDNA), plasma, report of risk score for advanced adenoma or colorectal cancer | 0326U | Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden |
As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management in one of several ways: - Access the ProviderPortalSM directly at providerportal.com:
- Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
- Access via Availity.com.
If you have questions related to guidelines, please contact Carelon via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. With your help, we can continually build towards a future of shared success. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-048270-23-CPN48141 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed. Please share this notice with other providers in your practice and office staff. To view a guideline, visit http://bit.ly/3GZ8ySE. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive: - SURG.00161 – Nanoparticle-Mediated Thermal Ablation:
- Nanoparticle-mediated thermal ablation is considered Investigational & Not Medically Necessary for all indications
- CG-LAB-29 – Gamma Glutamyl Transferase Testing:
- Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing of gamma glutamyl transferase (GGT) in blood
- CG-LAB-30 – Outpatient Laboratory-based Blood Glucose Testing:
- Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing to determine blood glucose concentration
Medical PoliciesOn May 11, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect March 1, 2024. Clinical UM GuidelinesOn May 11, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on June 22, 2023. These guidelines take effect March 1, 2024. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-047040-23-CPN43701 Prior Authorization | Commercial | February 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Claims Match Enhancement for Carelon Medical Benefits Management, Inc. Genetic TestingAs part of our ongoing quality improvement efforts, we will be implementing a new Genetic Testing (GT) claim to authorization match enhancement that will ensure GT panels billed have a corresponding authorization. This enhanced match logic will be effective by May 1, 2024. Labs that bill panels with codes in excess of what has been authorized may receive a full claim denial. The goal of this enhanced match logic is to ensure tests performed are authorized and meet medical necessity requirements. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047632-23-CPN47301 Effective March 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Precertification is required if the request is for gender affirming care services, including but not limited to diagnoses codes F64.0, F64.1, F64.2, F64.8, F64.9, or Z87.890. Ohio law prohibits Medicaid coverage of inpatient and outpatient hospital services relating to gender transformation. Code | Code Description | 11442 | Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm | 11446 | Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter over 4.0 cm | 11971 | Removal of tissue expander without insertion of implant | 11980 | Subcutaneous hormone pellet implantation (implantation of estradiol and/or testosterone pellets beneath the skin) | 13132 | Repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 2.6 cm to 7.5 cm | 13151 | Repair, complex, eyelids, nose, ears and/or lips; 1.1 cm to 2.5 cm | 13152 | Repair, complex, eyelids, nose, ears and/or lips; 2.6 cm to 7.5 cm | 13153 | Repair, complex, eyelids, nose, ears and/or lips; each additional 5 cm or less (List separately in addition to code for primary procedure) | 13160 | Secondary closure of surgical wound or dehiscence, extensive or complicated | 14020 | Adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10 sq cm or less | 14021 | Adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10.1 sq cm to 30.0 sq cm | 14301 | Adjacent tissue transfer or rearrangement, any area; defect 30.1 sq cm to 60.0 sq cm | 14302 | Adjacent tissue transfer or rearrangement, any area; each additional 30.0 sq cm, or part thereof (List separately in addition to code for primary procedure) | 15201 | Full thickness graft, free, including direct closure of donor site, trunk; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) | 15240 | Full thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet; 20 sq cm or less | 15241 | Full thickness graft, free, including direct closure of donor site, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands, and/or feet; each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) | 15273 | Application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children | 15274 | Application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (List separately in addition to code for primary procedure) | 15734 | Muscle, myocutaneous, or fasciocutaneous flap; trunk | 15738 | Muscle, myocutaneous, or fasciocutaneous flap; lower extremity | 15750 | Flap; neurovascular pedicle | 15777 | Implantation of biologic implant (for example, acellular dermal matrix) for soft tissue reinforcement (in other words, breast, trunk) (List separately in addition to code for primary procedure) | 15860 | Intravenous injection of agent (for example, fluorescein) to test vascular flow in flap or graft | 17110 | Destruction (for example, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 17111 | Destruction (for example, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions | 19370 | Revision of peri-implant capsule, breast, including capsulotomy, capsulorrhaphy, and/or partial capsulectomy | 19371 | Peri-implant capsulectomy, breast, complete, including removal of all intracapsular contents | 19499 | Unlisted procedure, breast | 21299 | Unlisted craniofacial and maxillofacial procedure | 21899 | Unlisted procedure, neck or thorax | 27656 | Repair, fascial defect of leg | 30460 | Rhinoplasty for nasal deformity secondary to congenital cleft lip and/or palate, including columellar lengthening; tip only | 31081 | Sinusotomy frontal; obliterative, without osteoplastic flap, coronal incision (includes ablation) | 31580 | Laryngoplasty; for laryngeal web, with indwelling keel or stent insertion | 31750 | Tracheoplasty; cervical | 40650 | Repair lip, full thickness; vermilion only | 40652 | Repair lip, full thickness; up to half vertical height | 40654 | Repair lip, full thickness; over one-half vertical height, or complex | 43496 | Free jejunum transfer with microvascular anastomosis | 44204 | Laparoscopy, surgical; colectomy, partial, with anastomosis | 44700 | Exclusion of small intestine from pelvis by mesh or other prosthesis, or native tissue (eg, bladder or omentum) | 45395 | Laparoscopy, surgical; proctectomy, complete, combined abdominoperineal, with colostomy | 45400 | Laparoscopy, surgical; proctopexy (for prolapse) | 51925 | Closure of vesicouterine fistula; with hysterectomy | 53210 | Urethrectomy, total, including cystostomy; female | 54120 | Amputation of penis; partial | 54522 | Orchiectomy, partial | 54692 | Laparoscopy, surgical; orchiopexy for intra-abdominal testis | 55150 | Resection of scrotum | 55250 | Vasectomy, unilateral or bilateral (separate procedure), including postoperative semen examination(s) | 55559 | Unlisted laparoscopy procedure, spermatic cord | 56620 | Vulvectomy simple; partial | 56630 | Vulvectomy, radical, partial; | 56633 | Vulvectomy, radical, complete; | 56640 | Vulvectomy, radical, complete, with inguinofemoral, iliac, and pelvic lymphadenectomy | 56700 | Partial hymenectomy or revision of hymenal ring | 57109 | Vaginectomy, partial removal of vaginal wall; with removal of paravaginal tissue (radical vaginectomy) with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy) | 57200 | Colporrhaphy, suture of injury of vagina (nonobstetrical) | 57282 | Colpopexy, vaginal; extra-peritoneal approach (sacrospinous, iliococcygeus) | 57425 | Laparoscopy, surgical, colpopexy (suspension of vaginal apex) | 58210 | Radical abdominal hysterectomy, with bilateral total pelvic lymphadenectomy and para-aortic lymph node sampling (biopsy), with or without removal of tube(s), with or without removal of ovary(s) | 58280 | Vaginal hysterectomy, with total or partial vaginectomy; with repair of enterocele | 62362 | Implantation or replacement of device for intrathecal or epidural drug infusion; programmable pump, including preparation of pump, with or without programming | 64912 | Nerve repair; with nerve allograft, each nerve, first strand (cable) | 67902 | Repair of blepharoptosis; frontalis muscle technique with autologous fascial sling (includes obtaining fascia) | 89398 | Unlisted reproductive medicine laboratory procedure | 92508 | Treatment of speech, language, voice, communication, and/or auditory processing disorder; group, 2 or more individuals |
To request PA, you may use one of the following methods: - Web: Once logged in to Availity at Availity.com.
- Fax:
- 877-643-0672 (physical health)
- 866-577-2183 (behavioral health)
- Phone: 800-601-9935
Not all PA requirements are listed here. Detailed PA requirements are available to providers on providers.anthem.com/oh on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at 844-912-1226 for assistance with PA requirements. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-049161-24-CPN49073 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0738T | Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination | 0739T | Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and int |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0443 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044235-23-CPN43832, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | Q4272 | Esano a, per square centimeter | Q4273 | Esano aaa, per square centimeter | Q4274 | Esano ac, per square centimeter | Q4275 | Esano aca, per square centimeter | Q4276 | Orion, per square centimeter | Q4277 | Woundplus membrane or e-graft, per square centimeter | Q4278 | Epieffect, per square centimeter | Q4280 | Xcell amnio matrix, per square centimeter | Q4281 | Barrera sl or barrera dl, per square centimeter | Q4282 | Cygnus dual, per square centimeter | Q4283 | Biovance tri-layer or biovance 3l, per square centimeter | Q4284 | Dermabind sl, per square centimeter |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0417 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044198-23-CPN43849, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA for Anthem Blue Cross and Blue Shield members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | E0761 | Non-Thermal Pulsed High Frequency Radiowaves, High Peak Power Electrom |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card for Provider Services. UM AROW #: A2023M0415 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044184-23-CPN43845, CPN-CRMMP-049296-24 Prior Authorization | Commercial | February 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Reimbursement policy update: Facility Guidelines for Claims Related to Professional Services — FacilityBeginning with dates of service on or after April 1, 2024, Anthem will not reimburse for the following when billed on a UB-04: - Consultation CPT® codes 99242–99245, 99251–99255
- Prolonged Services codes 99354–99359, 99415–99417 and G2212
For appropriate billing guidelines of Consultation and Prolonged Services CPT codes, please refer to the corresponding professional Reimbursement Policies: - Prolonged Services
- Consultation Services
For specific policy details, visit the reimbursement policy page at anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047188-23 Reimbursement Policies | Commercial | February 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements New reimbursement policy: Modifier Usage — FacilityBeginning with dates of service on or after May 1, 2024, Anthem will implement a new reimbursement policy titled Modifier Usage — Facility based on the code-set combinations submitted with the correct modifiers. This reimbursement policy identifies the following three different types of facility modifiers: - Reimbursement modifiers affect payment and denote circumstances when an increase or reduction is appropriate for the service provided.
- Informational modifiers impacting reimbursement determine if the service provided will be reimbursed or denied.
- Informational modifiers not impacting reimbursement are used for documentation purposes.
The Related Coding section of the policy includes a Facility Modifier code list which identifies the modifier, the modifier description, and any related reimbursement policies. The Facility Modifier code list also includes six modifiers that do not have associated reimbursement policies. These modifiers indicate a reduced service or different equipment was used for the service. These modifiers will result in a reduction when billed on a facility claim. For specific policy details, visit the reimbursement policy page at anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-047155-23-SRS47155 Pharmacy | Commercial | February 1, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Designated specialty pharmacy network updatesAs previously communicated, the Designated Specialty Pharmacy Network with Anthem requires care providers who are not part of it to acquire select specialty pharmacy medications through CVS Specialty Pharmacy if administered in the hospital outpatient setting. UpdatesEffective for dates of service on and after May 1, 2024, the following specialty pharmacy medications will be removed from the Designated Medical Specialty Pharmacy Drug List: HCPCS | Description | Brand name | J2503 | Injection, pegaptanib sodium, 0.3 mg | MACUGEN | J9023 | INJECTION AVELUMAB 10 MG | BAVENCIO | J9225 | HISTRELIN IMPLANT VANTAS 50 MG | VANTAS | J9266 | INJ PEGASPARGASE SINGLE DOSE VIAL | ONCASPAR | J0887 J0888 | INJECTION EPOETIN BETA 1 MICROGRAM ESRD INJECTION EPOETIN BETA 1 MICROGRAM NON-ESRD | MIRCERA | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | EPOGEN/PROCRIT | J0881 J0882 | INJ DARBEPOETIN ALFA 1 MCG NON-ESRD INJ DARBEPOETIN ALFA 1 MCG FOR ESRD | ARANESP | Q5106 | INJ EPOETIN ALFA-EPBX NON-ESRD BIOSIMLR 1000 UNIT | RETACRIT |
To access the current Designated Medical Specialty Pharmacy Drug List, please visit anthem.com/provider, select Providers, select Forms and Guides (under the Provider Resources column), select your state, scroll down, and select Pharmacy in the Category drop down. The Designated Medical Specialty Pharmacy Drug List may be updated periodically by Anthem. If you have questions or would like to discuss the terms and conditions to be included as a Designated Specialty Pharmacy Network care provider, please contact your contract manager with Anthem. Thank you for your continued participation in the Anthem networks and for the services you provide to our members. Beyond simply signing a contract, care providers are part of a genuine collaboration aimed at improving the lives of real people. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-048766-23 Pharmacy | Commercial | January 24, 2024 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Specialty pharmacy updates — February 2024This article was updated on July 23, 2024 to correct the Clinical Criteria for Spravato (esketamine) from CC-0066 to CC-0086. Specialty pharmacy updates for Anthem are listed belowPrior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s Medical Specialty Drug Review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updatesUpdate: In the May 2023 edition of Provider News, we announced prior authorization for Adstiladrin will be effective August 2023. Review of Adstiladrin is managed by Carelon Medical Benefits Management. Effective for dates of service on and after May 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0252 | Adzynma (ADAMTS13, recombinant-krhn) | C9399 | CC-0253* | Aphexda (motixafortide) | J3490, J3590, J9999 | CC-0042 | Bimzelx (bimekizumab-bkzx) | J3490 | CC-0032 | Daxxify (daxibotulinumtoxinA-lanm) | C9160 | CC-0050 | Omvoh (mirikizumab-mrkz) | J3590 | CC-0066* | Tofidence (tocilizumab-bavi) | J3490, J3590 | CC-0254 | Zilbysq (zilucoplan) | J3490 | CC-0062 | Zymfentra (infliximab-dyyb) | J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Quantity limit updatesEffective for dates of service on and after May 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0042 | Bimzelx (bimekizumab-bkzx) | J3490 | CC-0032 | Daxxify (daxibotulinumtoxinA-lanm) | C9160 | CC-0050 | Omvoh (mirikizumab-mrkz) | J3590 | CC-0066 | Tofidence (tocilizumab-bavi) | J3490, J3590 | CC-0254 | Zilbysq (zilucoplan) | J3490 | CC-0062 | Zymfentra (infliximab-dyyb) | J3590 | CC-0086 | Spravato (esketamine) | G2082, G2083, S0013 |
Through our efforts, we are committed to reducing administrative burden and ensuring timely payments because we value you, our care provider partners. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-048938-24-CPN48884 This article was published in error and retracted on February 23, 2024. Please access your state's updated version: Colorado, Connecticut, Georgia, Indiana, Kentucy, Missouri, Nevada, New Hampshire, New York, Ohio, Virginia, Wisconsin Effective for dates of service on and after May 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines (including definitions and specific contract provisions/exclusions), take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
HCPCS or CPT® codes
| Medicare Part B drugs
| J3490, J3590, J9999, C9399
| Elrexfio (elranatamab-bcmm)
| J3490, J3590
| Eylea HD (aflibercept)
| J3490, J3590
| Pombiliti (cipaglucosidase alfa-atga)
| J3490, J3590, J9999, C9399
| Talvey (talquetamab-tgvs)
| J3490, J3590
| Tyruko (natalizumab-sztn)
| J3590, C9399
| Veopoz (pozelimab-bbfg)
| J3490
| Ycanth (cantharidin)
|
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-046706-23-CPN45768 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes. Select here for our conversation guide for tips on how to engage patients who may be from a culture different from your own.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services on the back of your patient’s member ID card. Through our efforts, we can help deliver high quality, equitable healthcare. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-040701-23-CPN39313 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services at 844-912-1226. Through our efforts, we can help deliver high quality, equitable healthcare. OHBCBS-CD-040698-23-CPN39313 Hispanics are the largest ethnic minority group in the United States, making it vital that we recognize the unique health needs of the population. Take time in February to support American Heart Health Month and explore how your practice can help improve your Hispanic patients’ heart health. What can your practice do to help improve health outcomes for Hispanic patients with heart disease?- Be proactive about asking if the patient requires interpretation services. No one wants to feel like a burden. By asking and preparing for an interpreter in advance, you are creating a welcoming atmosphere for the patient during their appointment. If you would like to request an interpreter, including sign language, on behalf of your Anthem Blue Cross and Blue Shield patients, call Provider Services. Free interpreter services are also available to members by calling the Member's Services number on the back of their ID card (TTY/TTD 711) and through the 24/7 NurseLine.
- According to a study by the American Heart Association (link), Hispanic persons had similar rates of heart disease compared to Caucasian adults but lower rates of awareness and control. To help increase awareness of their condition, you can ask questions such as:
- “Have you ever been told that you have high blood pressure or high cholesterol?”
- “Has a healthcare provider ever discussed with you or prescribed you medication to control your blood pressure or cholesterol levels?”
- Once awareness of the condition is properly understood, educate the patient on any increased health risk factors they might have, especially if they have other conditions like diabetes or obesity.
- Use culturally appropriate examples when discussing lifestyle changes. Select here for our conversation guide for tips on how to engage patients who may be from a culture different from your own.
- Encourage scheduling follow-up appointments for blood pressure rechecks or lab work to check cholesterol levels before the patient leaves the office.
- Submit all blood pressure readings using Category II codes on claims or through your practice’s preferred supplemental data submission method. Blood pressure care gaps can open and close through the year and are based on the last recorded blood pressure reading of the year. The goal for every patient is a reading below 140/90 mmHg.
- Properly code statin therapy exclusions and prescribe low-cost medications to discourage the use of discount cards.
To learn more about our commitment to health equity, visit MyDiversePatients.com. Your patients can also learn more about the unique health needs of Hispanic persons by visiting takingactionforourhealth.org/. Patient care opportunitiesIf you have questions on improving your quality scores, contact your care consultant or program manager to discuss your opportunities. You also can find patient care opportunities within the Patient360 application located on Availity Essentials Payer Spaces. To access the Patient360 application you must have the Patient360 role assignment. From Availity’s home page, select Payer Spaces, then choose the health plan from the menu. Choose the Patient360 tile from the Payer Space Applications menu and complete the required information on the screen. Gaps in care are in the Active Alerts section of the Member Summary. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management associate or call Provider Services on the back of your patient’s member ID card. Through our efforts, we can help deliver high quality, equitable healthcare. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-040702-23-CPN39313 |